These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38862179)

  • 61. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.
    Sardella G; Beerkens FJ; Dangas G; Cao D; Baber U; Sartori S; Cohen DJ; Briguori C; Gil R; Nicolas J; Zhang Z; Dudek D; Kunadian V; Kornowski R; Weisz G; Claessen B; Marx S; Escaned J; Huber K; Collier T; Moliterno DJ; Ohman EM; Krucoff MW; Kastrati A; Steg PG; Angiolillo DJ; Mehta S; Shlofmitz R; Sharma S; Pocock S; Gibson CM; Mehran R
    EuroIntervention; 2022 Dec; 18(11):e897-e909. PubMed ID: 35979636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ticagrelor monotherapy versus aspirin in patients undergoing multiple arterial or single arterial coronary artery bypass grafting: insights from the TiCAB trial.
    Sandner SE; Schunkert H; Kastrati A; Wiedemann D; Misfeld M; Böning A; Tebbe U; Nowak B; Stritzke J; Laufer G; von Scheidt M;
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):732-739. PubMed ID: 31750899
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
    Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
    Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.
    Tomaniak M; Chichareon P; Modolo R; Takahashi K; Chang CC; Kogame N; Spitzer E; Buszman PE; van Geuns RM; Valkov V; Steinwender C; Geisler T; Prokopczuk J; Sabaté M; Zmudka K; Rademaker-Havinga T; Tijssen JGP; Jüni P; Hamm C; Steg PG; Onuma Y; Vranckx P; Valgimigli M; Windecker S; Baber U; Anderson R; Dominici M; Serruys PW
    EuroIntervention; 2020 Apr; 15(18):e1605-e1614. PubMed ID: 31845894
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial.
    Ono M; Chichareon P; Tomaniak M; Kawashima H; Takahashi K; Kogame N; Modolo R; Hara H; Gao C; Wang R; Walsh S; Suryapranata H; da Silva PC; Cotton J; Koning R; Akin I; Rensing BJWM; Garg S; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Steg PG; Valgimigli M; Windecker S; Storey RF; Onuma Y; Vranckx P; Serruys PW
    Clin Res Cardiol; 2020 Sep; 109(9):1125-1139. PubMed ID: 32006156
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
    Baber U; Dangas G; Angiolillo DJ; Cohen DJ; Sharma SK; Nicolas J; Briguori C; Cha JY; Collier T; Dudek D; Džavik V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta S; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM; Mehran R
    Eur Heart J; 2020 Oct; 41(37):3533-3545. PubMed ID: 33085967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.
    Franzone A; McFadden E; Leonardi S; Piccolo R; Vranckx P; Serruys PW; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; Diletti R; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Steg PG; Heg D; Jüni P; Windecker S; Valgimigli M;
    J Am Coll Cardiol; 2019 Nov; 74(18):2223-2234. PubMed ID: 31672177
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS Trial.
    Vranckx P; Valgimigli M; Odutayo A; Serruys PW; Hamm C; Steg PG; Heg D; Mc Fadden EP; Onuma Y; Benit E; Janssens L; Diletti R; Ferrario M; Huber K; Räber L; Windecker S; Jüni P;
    J Am Heart Assoc; 2021 Sep; 10(18):e015560. PubMed ID: 34533034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
    Wang Y; Pan Y; Li H; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Birve F; Ladenvall P; Molina CA; Johnston SC;
    JAMA Neurol; 2021 Sep; 78(9):1091-1098. PubMed ID: 34244703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.
    Hage A; Voisine P; Erthal F; Larose É; Glineur D; Chow B; Tremblay H; Fortier J; Ko G; Une D; Farkouh M; Mesana TG; LeMay M; Kulik A; Ruel M
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):212-222.e2. PubMed ID: 28734623
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
    Timmis A; Rapsomaniki E; Chung SC; Pujades-Rodriguez M; Moayyeri A; Stogiannis D; Shah AD; Pasea L; Denaxas S; Emmas C; Hemingway H
    BMJ; 2016 Jun; 353():i3163. PubMed ID: 27334486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials.
    Ning C; Ling F; Liu D; Zhi Z
    BMC Cardiovasc Disord; 2024 Mar; 24(1):166. PubMed ID: 38504170
    [TBL] [Abstract][Full Text] [Related]  

  • 73. P2Y12 Inhibitor Monotherapy Versus Conventional Dual Antiplatelet Therapy or Aspirin Monotherapy in Acute Coronary Syndrome: A Pooled Analysis of the SMART-DATE and SMART-CHOICE Trials.
    Song PS; Park YH; Oh JH; Song YB; Choi SH; Gwon HC; Cho DK; Rha SW; Bae JW; Jeong JO; Hahn JY;
    Am J Cardiol; 2021 Jul; 150():47-54. PubMed ID: 34011436
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ticagrelor-based antiplatelet regimens in patients treated with coronary artery bypass grafting: a meta-analysis of randomized controlled trials.
    von Scheidt M; Bongiovanni D; Tebbe U; Nowak B; Stritzke J; Zhao Q; Zhu Y; Kastrati A; Cassese S; Schunkert H
    Eur J Cardiothorac Surg; 2020 Mar; 57(3):520-528. PubMed ID: 31566205
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
    Leiter LA; Bhatt DL; McGuire DK; Teoh H; Fox K; Simon T; Mehta SR; Lev EI; Kiss RG; Dalby AJ; Bueno H; Ridderstråle W; Himmelmann A; Prats J; Liu Y; Lee JJ; Amerena J; Kosiborod MN; Steg PG;
    J Am Coll Cardiol; 2021 May; 77(19):2366-2377. PubMed ID: 33985681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
    Charif F; Hamdan R; Youness G; El Zein A; Issa M; Jassar Y; Younes M; Saab M
    J Cardiothorac Surg; 2019 Nov; 14(1):202. PubMed ID: 31775803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.
    Takahashi K; Serruys PW; Chichareon P; Chang CC; Tomaniak M; Modolo R; Kogame N; Magro M; Chowdhary S; Eitel I; Zweiker R; Ong P; Ottesen MM; Tijssen JGP; Wykrzykowska JJ; de Winter RJ; Garg S; Stoll HP; Hamm C; Steg PG; Onuma Y; Valgimigli M; Vranckx P; Carrie D; Windecker S
    J Am Coll Cardiol; 2019 Oct; 74(16):2015-2027. PubMed ID: 31623758
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
    Li J; Ju J; Chen Z; Liu J; Lu F; Gao R; Xu H
    Trials; 2018 Feb; 19(1):93. PubMed ID: 29415754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.